Concepedia

Publication | Open Access

Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trial

19

Citations

14

References

2025

Year

Abstract

European Commission H2020 Programme; French Health Ministry PHRC2014; and Motor Neurone Disease Association.

References

YearCitations

Page 1